Larue v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided September 4, 2026·No. 19-1135V·Published

Opinion

In the United States Court of Federal Claims No. 19-1135

Filed: August 14, 2026 Reissued: September 4, 2026 † **SEALED**

CANDY LARUE,

Petitioner,

v.

SECRETARY OF HEALTH AND HUMAN SERVICES,

Respondent.

John L. De Fazio, Viola, Cummings, Lindsay, & Mosher, LLP, Niagara Falls, NY, for Petitioner.

Sara Destefano, Trial Attorney, Jennifer L. Reynaud, Assistant Director, Heather L. Pearlman, Deputy Director, Jonathan D. Guynn, Acting Director, Torts Branch, Civil Division, Brett A. Schumate, Assistant Attorney General, U.S. Department of Justice, Washington, DC, for Respondent.

MEMORANDUM OPINION AND ORDER

TAPP, Judge.

Petitioner, Candy LaRue, (“Ms. LaRue”), seeks reversal of the Special Master’s decision denying her compensation claim pursuant to the National Childhood Vaccine Injury Act (“Vaccine Act”). Ms. LaRue alleged that a vaccination caused her to develop an autoimmune neurological disorder. The Special Master determined she had not proven causation by a preponderance of the evidence and denied entitlement. Ms. LaRue now moves for review. 1 (Pet’r’s Mot. at 1, ECF No. 83). Ms. LaRue primarily argues that the Special Master failed to

† The Court originally issued this Opinion under seal on August 14, 2026. (ECF No. 86). The Court provided parties the opportunity to review this Opinion for any proprietary, confidential, or other protected information and submit proposed redactions no later than August 31, 2026. To date, the parties have not proposed redactions. Thus, the sealed and public versions of this Opinion are identical, except for the publication date and this footnote. 1 Ms. LaRue filed a Motion for Review, (ECF No. 81), and a separate Memorandum of Objections, (ECF No. 83). Because the Memorandum of Objections contains the substance of her arguments, the Court refers to it as the pending motion.

evaluate relevant evidence, wrongly discounted testimony, and effectively held Ms. LaRue to an unduly high burden. However, the Court finds that the Special Master did not act arbitrarily or capriciously, abuse her discretion, or rule contrary to law. Accordingly, Ms. LaRue’s Motion for Review is DENIED.

I. Background

On August 22, 2016, a staff nurse at a family practitioner’s office administered Ms.

LaRue’s influenza virus vaccination. (Petition (“Pet.”) at 1, ECF No. 1). At the time, Ms. LaRue was in remission from Chronic Lymphocytic Leukemia (“CLL”), which she was diagnosed with in 2010. 2 (Id. at 2). Ms. LaRue claims that she began experiencing weakness in her legs and tingling in her arms within a few days of receiving the vaccine. (Id.). At an appointment with her treating specialist approximately two weeks after receiving the vaccine, Ms. LaRue complained of bone soreness and fatigue. (Id.). Her doctor advised a bone marrow biopsy to test whether her CLL had relapsed. (Id.). In December 2016, the biopsy results ruled out CLL. (Id.). When Ms. LaRue’s symptoms did not alleviate, she saw another doctor in February 2017 who diagnosed her with low iron and administered unsuccessful iron therapy. (Id. at 3). A month later, Ms. LaRue went to a neurologic institute where she was diagnosed with Guillain-Barré syndrome (“GBS”). 3 (Id.). Doctors updated her diagnosis to chronic inflammatory demyelinating polyneuropathy (“CIDP”). 4 (Entitlement Decision at 7 (citing Pet’r’s Ex. 1 at 183–84, ECF No.

2 CLL is a slow-progressing cancer of the blood or bone marrow. See Monique Leahy, 7 Attorneys Medical Advisor § 58:17. 3 GBS is “a rare disorder in which your body’s immune system attacks your nerves. Weakness and tingling in your hands and feet are usually the first symptoms.” Gamboa-Avila v. Sec’y of Health & Hum. Servs., 170 Fed. Cl. 441, 443 (2024) (citation omitted), aff’d, 166 F.4th 1318 (Fed. Cir. 2026). 4 Because Ms. Larue’s GBS diagnosis was updated to CIDP on August 8, 2017, the Court consistently refers to her diagnosis as CIDP regardless of the time frame. (See Entitlement Decision at 25). CIDP “generally is defined as ‘a slowly progressive, autoimmune type of demyelinating polyneuropathy characterized by progressive weakness and impaired sensory function in the limbs and enlargement of the peripheral nerves.’” Beale v. Sec’y of Health & Hum. Servs., No. 23-1326V, 2026 WL 1244394, at *18 (Fed. Cl. Apr. 8, 2026) (citation omitted).

1-4)). 5 Since that diagnosis, Ms. LaRue experienced several hospitalizations and continued symptoms, including urosepsis and paralysis from the neck down. 6 (Pet. at 3).

In August 2019, Ms. LaRue sought compensation for injuries she alleges the influenza vaccine caused. 7 (Pet. at 5–6). Ms. LaRue claims her symptoms onset in September 2016, while the Secretary contends that symptoms did not present until November 2016. (Entitlement Decision at 16–17). After a status conference flagged contradictions between Ms. LaRue’s self- reported onset of symptoms and apparent onset reflected in her medical records, Ms. LaRue filed affidavits from herself, friends, and coworkers to establish her onset timeline of approximately September 2016 to October 2016. (Id. at 1–2). At a second status conference, the Special Master explained that the record still provided “‘no documentary support for the facts submitted by [Ms. LaRue] and her witnesses’ regarding onset.’” (Id. at 2 (citing ECF No. 46 at 2)). Subsequently, Ms. LaRue moved for a ruling on the record. (Id.).

The Special Master ultimately found Ms. LaRue failed to provide preponderant evidence of causation, including an onset timeline. (Entitlement Decision at 1, 22). Under controlling case law, Ms. LaRue failed to meet the three requirements to demonstrate causation-in-fact. (Id. (referencing Althen v. Sec’y of Health & Hum. Servs., 418 F.3d 1274 (Fed. Cir. 2005)). The Special Master found that Ms. LaRue failed to provide sufficient evidence that her CIDP developed within a plausible temporal relationship to the vaccine because medical records showing onset outside the medically acceptable timeframe outweighed lay testimony placing her onset within that timeframe. (Id. at 23–24). Stated differently, the Special Master found that this later onset did not comport with a medically acceptable timeframe for a causal link with her vaccine. (Id. at 24). Moreover, the Special Master found that Ms. LaRue’s expert’s proposed onset timeline lacked relevance to her case because it did not address CIDP specifically. (Id.). In addition, Ms. LaRue did not prove by a preponderance that the vaccination was the “but for” cause of her CIDP given her extensive pre-vaccination medical history and lack of medical literature or record support. 8 (Id.). The medical records noting a possible link between the

5 LaRue v. Sec’y of Health & Hum. Servs., No. 19-1135V, 2026 WL 1649726, at *1 (Fed. Cl. May 11, 2026) (docketed at ECF No. 80). For consistency with the parties’ briefing, the Court refers to this decision as “Entitlement Decision” and cites to the page numbers of the docketed version. 6 Urosepsis is a “[s]epsis from obstruction of infected urine.” Urosepsis, Stedmans Medical Dictionary 961830, Westlaw (database updated Nov. 2014). 7 Two Special Masters oversaw Ms. LaRue’s claim. Special Master Roth initially presided, holding status conferences, granting subpoenas, and requesting additional supporting evidence until March 17, 2026. (See Entitlement Decision at 1–2). The case was then reassigned to Special Master Young who ruled on the record. (Id. at 2). 8 Ms. LaRue’s pre-vaccination medical history includes “stage III CLL, Barrett’s esophagus, lymphocytosis, right lower quadrant pain, night sweats, syncope, anemia from chemotherapy,

vaccine and her symptoms relied solely on Ms. LaRue’s self-reported GBS diagnosis and her own explanation of the vaccine’s role. (Id. at 25).

II. Analysis

Ms. LaRue moves for reversal of the Special Master’s Entitlement Decision. (Pet’r’s Mot.

Free access — add to your briefcase to read the full text and ask questions with AI

Larue v. Secretary of Health and Human Services, (uscfc 2026).

Larue v. Secretary of Health and Human Services (Larue v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Doe v. Secretary of Health and Human Services
601 F.3d 1349 (Federal Circuit, 2010)
Cedillo v. Secretary of Health & Human Services
617 F.3d 1328 (Federal Circuit, 2010)
Broekelschen v. Secretary of Health & Human Services
618 F.3d 1339 (Federal Circuit, 2010)
De Bazan v. Secretary of Health and Human Services
539 F.3d 1347 (Federal Circuit, 2008)
Althen v. Secretary of Health and Human Services
418 F.3d 1274 (Federal Circuit, 2005)
Stone v. Secretary of Health and Human Services
676 F.3d 1373 (Federal Circuit, 2012)
Griglock v. Secretary of Health & Human Services
687 F.3d 1371 (Federal Circuit, 2012)
Lombardi v. Secretary of Health and Human Services
656 F.3d 1343 (Federal Circuit, 2011)
Porter v. Secretary of Health and Human Services
663 F.3d 1242 (Federal Circuit, 2011)
Paluck v. Secretary of Health & Human Services
786 F.3d 1373 (Federal Circuit, 2015)
Moriarty v. Secretary of Health & Human Services
844 F.3d 1322 (Federal Circuit, 2016)
Milik v. Secretary of Health & Human Services
822 F.3d 1367 (Federal Circuit, 2016)